Ratings by Guggenheim (Subbu Nambi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2026 | Nautilus Biotechnology | NAUT | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Sophia Genetics SA | SOPH | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | GRAIL, Inc. | GRAL | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Neogen | NEOG | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Waters Corp. | WAT | New Coverage | Buy (N/A) |
394.97 (302.54) |
-23.4% | Details | |
| 1/6/2026 | BillionToOne Inc | BLLN | New Coverage | Buy (N/A) |
95.00 (73.51) |
-22.62% | Details | |
| 1/5/2026 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | Bruker | BRKR | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Exact Sciences | EXAS | Downgrade | Neutral (Buy) |
86.18 (103.50) |
20.1% | Details | |
| 11/12/2025 | GRAIL, Inc. | GRAL | Upgrade | Buy (Neutral) |
83.39 (50.23) |
-39.76% | Details | |
| 11/11/2025 | Personalis | PSNL | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2025 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2025 | Illumina | ILMN | Maintain | Buy (Buy) |
|
Details | ||
| 10/16/2025 | Revvity Inc | RVTY | New Coverage | Neutral (N/A) |
91.14 (91.34) |
0.22% | Details | |
| 9/30/2025 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Buy (N/A) |
13.46 (14.86) |
10.4% | Details | |
| 9/26/2025 | Tempus AI Inc | TEM | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Caris Life Sciences Inc | CAI | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2025 | Caris Life Sciences Inc | CAI | New Coverage | Buy (N/A) |
26.62 (18.59) |
-30.17% | Details | |
| 6/30/2025 | GeneDx | WGS | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2025 | Tempus AI Inc | TEM | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2025 | Neogen | NEOG | Maintain | Buy (N/A) |
|
Details | ||
| 5/15/2025 | GeneDx | WGS | New Coverage | Buy (N/A) |
59.45 (88.11) |
48.21% | Details | |
| 5/15/2025 | Neogenomics | NEO | New Coverage | Neutral (N/A) |
7.96 (8.96) |
12.56% | Details | |
| 5/9/2025 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 4/10/2025 | Neogen | NEOG | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2025 | Veracyte, Inc | VCYT | Maintain | Buy (N/A) |
|
Details | ||
| 4/9/2025 | Myriad Genetics | MYGN | Downgrade | Neutral (Buy) |
8.07 (5.15) |
-36.18% | Details | |
| 3/28/2025 | Twist Bioscience | TWST | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Illumina | ILMN | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Danaher | DHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | CryoPort | CYRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2025 | Castle Biosciences | CSTL | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Nautilus Biotechnology | NAUT | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2025 | Guardant Health | GH | Maintain | Buy (N/A) |
|
Details | ||
| 1/17/2025 | Natera | NTRA | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2024 | Bruker | BRKR | New Coverage | Buy (N/A) |
55.38 (36.68) |
-33.77% | Details | |
| 12/19/2024 | Neogen | NEOG | New Coverage | Buy (N/A) |
11.64 (9.70) |
-16.67% | Details | |
| 12/19/2024 | Maravai LifeScience Holdings Inc. | MRVI | New Coverage | Neutral (N/A) |
5.58 (3.55) |
-36.38% | Details | |
| 12/19/2024 | Danaher | DHR | New Coverage | Buy (N/A) |
228.30 (195.50) |
-14.37% | Details | |
| 12/19/2024 | CryoPort | CYRX | New Coverage | Buy (N/A) |
7.79 (8.09) |
3.85% | Details | |
| 12/9/2024 | Tempus AI Inc | TEM | New Coverage | Buy (N/A) |
50.44 (52.26) |
3.61% | Details | |
| 10/17/2024 | GRAIL, Inc. | GRAL | New Coverage | Neutral (N/A) |
14.32 (83.39) |
482.33% | Details | |
| 10/10/2024 | Veracyte, Inc | VCYT | New Coverage | Buy (N/A) |
31.92 (33.85) |
6.05% | Details | |
| 6/28/2024 | Guardant Health | GH | Upgrade | Buy (Neutral) |
29.05 (91.20) |
213.94% | Details | |
| 6/27/2024 | Sophia Genetics SA | SOPH | New Coverage | Buy (N/A) |
4.46 (4.35) |
-2.47% | Details | |
| 6/27/2024 | Nautilus Biotechnology | NAUT | New Coverage | Buy (N/A) |
2.22 (2.47) |
11.26% | Details | |
| 6/25/2024 | 10X Genomics | TXG | Downgrade | Neutral (Buy) |
19.88 (20.81) |
4.68% | Details | |
| 6/18/2024 | Repligen | RGEN | New Coverage | Neutral (N/A) |
124.35 (119.99) |
-3.51% | Details | |
| 12/14/2023 | Castle Biosciences | CSTL | New Coverage | Buy (N/A) |
19.99 (27.12) |
35.67% | Details | |
| 12/14/2023 | Myriad Genetics | MYGN | New Coverage | Buy (N/A) |
19.05 (5.15) |
-72.97% | Details | |
| 12/14/2023 | Guardant Health | GH | New Coverage | Neutral (N/A) |
26.79 (91.20) |
240.43% | Details | |
| 12/14/2023 | Natera | NTRA | New Coverage | Buy (N/A) |
58.52 (198.13) |
238.57% | Details | |
| 12/14/2023 | Exact Sciences | EXAS | New Coverage | Buy (N/A) |
65.52 (86.18) |
31.53% | Details | |
| 12/14/2023 | Akoya Biosciences Inc | AKYA | New Coverage | Neutral (N/A) |
4.26 (1.29) |
-69.72% | Details | |
| 12/14/2023 | Pacific Biosciences of California | PACB | New Coverage | Neutral (N/A) |
8.31 (1.38) |
-83.39% | Details | |
| 12/14/2023 | Illumina | ILMN | New Coverage | Buy (N/A) |
117.64 (124.62) |
5.93% | Details | |
| 12/14/2023 | 10X Genomics | TXG | New Coverage | Buy (N/A) |
48.64 (20.81) |
-57.22% | Details |
